- Home
- CELC vs BCML Comparison
CELC vs BCML Comparison
Compare CELC & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BCML
- Stock Information
- Founded
- CELC 2011
- BCML 2004
- Country
- CELC United States
- BCML United States
- Employees
- CELC N/A
- BCML N/A
- Industry
- CELC Medical Specialities
- BCML Major Banks
- Sector
- CELC Health Care
- BCML Finance
- Exchange
- CELC Nasdaq
- BCML Nasdaq
- Market Cap
- CELC 327.3M
- BCML 279.0M
- IPO Year
- CELC 2017
- BCML N/A
- Fundamental
- Price
- CELC $10.15
- BCML $26.83
- Analyst Decision
- CELC Strong Buy
- BCML
- Analyst Count
- CELC 6
- BCML 0
- Target Price
- CELC $30.17
- BCML N/A
- AVG Volume (30 Days)
- CELC 190.9K
- BCML 29.9K
- Earning Date
- CELC 05-14-2025
- BCML 04-17-2025
- Dividend Yield
- CELC N/A
- BCML 2.24%
- EPS Growth
- CELC N/A
- BCML N/A
- EPS
- CELC N/A
- BCML 2.10
- Revenue
- CELC N/A
- BCML $95,714,000.00
- Revenue This Year
- CELC N/A
- BCML $3.39
- Revenue Next Year
- CELC N/A
- BCML $6.76
- P/E Ratio
- CELC N/A
- BCML $12.78
- Revenue Growth
- CELC N/A
- BCML N/A
- 52 Week Low
- CELC $7.58
- BCML $18.54
- 52 Week High
- CELC $19.77
- BCML $30.13
- Technical
- Relative Strength Index (RSI)
- CELC 46.58
- BCML 58.85
- Support Level
- CELC $9.64
- BCML $26.01
- Resistance Level
- CELC $10.80
- BCML $27.77
- Average True Range (ATR)
- CELC 0.66
- BCML 0.94
- MACD
- CELC -0.06
- BCML 0.09
- Stochastic Oscillator
- CELC 25.25
- BCML 64.12
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.